Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment – Motley Fool

Remdesivir, the only antiviral drug authorized to deal with COVID-19 could become even more accessible quickly. On Monday, Gilead Sciences(NASDAQ: GILD) ended up submitting a new drug application (NDA) to the … [+1775 chars]